-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Men 2010: 12th International…
16–18 September, 2010
This two-day meeting will provide a forum for educating basic and clinical…
-
Ribonuclease H2010
20–22 September, 2010
We expect to bring together scientists interested in making as much…
-
Third Annual Ultra Orphan…
27–29 September, 2010
Centric Health Resources Presents Third Annual Ultra Orphan Conference…
-
Brain, Blood and Iron: Joint…
1–2 October, 2010
The overall objectives of this workshop are to (1) define NA and NBIA…
Events
-
Copy Number Variation Found to Cause Rare Kidney Disease
Thursday, August 26, 2010
A rare form of kidney disease linked to a genetic mutation in the innate immune system has been identified by researchers funded by the Wellcome Trust and the Medical Research CouncilSo far, the disease, which the researchers have named CFHR5 nephropathy, has been identified in over one hundred pe
-
Gene Involved in Fuchs Corneal Dystrophy Is Found
Thursday, August 26, 2010
A 13-member research team led by University of Oregon scientist Dr. Albert O. Edwards has found a gene likely responsible for Fuchs corneal dystrophy, an inheritable genetic disorder and leading cause of corneal transplant operationsEdwards performed a genome-wide analysis comparing patients with
-
Scientists Discover MRS Can Rapidly Diagnose Degenerative Disorders
Wednesday, August 25, 2010
Magnetic Resonance Spectroscopy can distinguish between neurological diseases in patients without clear symptomsA team of American scientists claim that a new method of testing for neurological diseases could provide doctors with a rapid and non-invasively method of diagnosing degenerative disorde
-
Alnylam and Collaborators Publish New Pre-Clinical Research on Therapeutic Silencing of Parkinson's Disease Gene
Wednesday, August 25, 2010
CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoSThe new data show effective silencing of the
-
Mayo Researchers Develop New Laboratory Cell Lines to Study Treatment for ATC
Wednesday, August 25, 2010
JACKSONVILLE, Fla. -- To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancerIt quickly became evident t
-
Double-Therapy Approach Effectively Inhibited Brain Cancer Recurrence
Wednesday, August 25, 2010
PHILADELPHIA -- Researchers from the University of Massachusetts Medical School have identified a novel approach of combining chemotherapy with a targeted therapy to decrease the recurrence of glioblastoma multiforme, the most common and aggressive brain tumor"Glioblastomas are horrendous tumors,
-
Researchers Find Gene Responsible for Neurodegenerative Disease in Dogs, Possibly in Humans
Tuesday, August 24, 2010
A North Carolina State University researcher has helped to locate and identify a gene responsible for a fatal neurodegenerative disease that affects American Staffordshire terriersThis same gene may be responsible for a similar rare, fatal disease in humans. Its discovery will lead to improved scr
-
A Promising Target for Developing Treatments Against Parkinson's Disease
Tuesday, August 24, 2010
Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's diseaseThe researchers' findings are published in the August 22 issue of Nature MedicineThe newly discovered drugs block a protein that, when altered in people,
-
Taligen Granted Patent for Lead Product Candidate, TT30, and Other Compounds Targeting the Complement System
Tuesday, August 24, 2010
CAMBRIDGE, Mass. -- Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled “Targeting Complement
-
Virtual Colonoscopies Help Identify Additional Cancers Outside of the Colon, Study Suggests
Tuesday, August 24, 2010
Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early
